Patent Litigation Settlement and License between Merck Millipore and W. L. Gore & Associates, Inc.
News May 02, 2013
Gore has agreed to take a limited royalty-bearing license under U.S. Patent Nos. 7,293,744 and 7,927,316 and U.S. Reissue No. RE41,169, and their counterparts internationally in connection with its STA-PURE Fluid Sampling Systems and assemblies, Crimp and Cut tools, and STA-PURE Single Use Valve Systems and assemblies.
"Our customers rely on us to be technology leaders for innovation in biopharmaceutical production and, as such, Merck Millipore will continue to vigorously defend its intellectual property," said Andrew Bulpin, Executive Vice President for Merck Millipore Process Solutions.
Tailor-made Protein Fights Several Species of BacteriaNews
As resistance to existing antibiotics increases, new approaches to serious bacterial infections are needed. Now researchers have investigated one such alternative.READ MORE
First Successful Gene Therapy Trial Reported for People with Hemophilia ANews
Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.READ MORE